Australia
· Delayed Price · Currency is AUD Universal Biosensors Statistics
Total Valuation
ASX:UBIO has a market cap or net worth of AUD 18.48 million. The enterprise value is 13.95 million.
| Market Cap | 18.48M |
| Enterprise Value | 13.95M |
Important Dates
The next estimated earnings date is Monday, April 28, 2025.
| Earnings Date | Apr 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +27.32% |
| Shares Change (QoQ) | +0.07% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 189.86M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.94 |
| PB Ratio | 1.06 |
| P/TBV Ratio | 1.06 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.98 |
| EV / Sales | 2.22 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -1.10 |
Financial Position
The company has a current ratio of 3.96, with a Debt / Equity ratio of 0.23.
| Current Ratio | 3.96 |
| Quick Ratio | 2.04 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.32 |
| Interest Coverage | -826.04 |
Financial Efficiency
Return on equity (ROE) is -77.22% and return on invested capital (ROIC) is -46.25%.
| Return on Equity (ROE) | -77.22% |
| Return on Assets (ROA) | -38.00% |
| Return on Invested Capital (ROIC) | -46.25% |
| Return on Capital Employed (ROCE) | -80.12% |
| Revenue Per Employee | 82,668 |
| Profits Per Employee | -187,365 |
| Employee Count | 76 |
| Asset Turnover | 0.23 |
| Inventory Turnover | 0.46 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 58.68 |
| Average Volume (20 Days) | 119,823 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:UBIO had revenue of AUD 6.28 million and -14.24 million in losses. Loss per share was -0.05.
| Revenue | 6.28M |
| Gross Profit | 4.00M |
| Operating Income | -16.97M |
| Pretax Income | -14.24M |
| Net Income | -14.24M |
| EBITDA | -16.17M |
| EBIT | -16.97M |
| Loss Per Share | -0.05 |
Balance Sheet
The company has 8.54 million in cash and 4.01 million in debt, giving a net cash position of 4.53 million.
| Cash & Cash Equivalents | 8.54M |
| Total Debt | 4.01M |
| Net Cash | 4.53M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 17.37M |
| Book Value Per Share | 0.06 |
| Working Capital | 13.81M |
Cash Flow
In the last 12 months, operating cash flow was -12.30 million and capital expenditures -412,727, giving a free cash flow of -12.71 million.
| Operating Cash Flow | -12.30M |
| Capital Expenditures | -412,727 |
| Free Cash Flow | -12.71M |
| FCF Per Share | n/a |
Margins
Gross margin is 63.70%, with operating and profit margins of -270.08% and -226.65%.
| Gross Margin | 63.70% |
| Operating Margin | -270.08% |
| Pretax Margin | -226.65% |
| Profit Margin | -226.65% |
| EBITDA Margin | -257.30% |
| EBIT Margin | -270.08% |
| FCF Margin | n/a |
Dividends & Yields
ASX:UBIO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -27.32% |
| Shareholder Yield | -27.32% |
| Earnings Yield | -77.05% |
| FCF Yield | -68.79% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ASX:UBIO has an Altman Z-Score of -4.6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.6 |
| Piotroski F-Score | n/a |